𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progesterone binding cyst protein (PBCP) in primary breast cancer: A new prognostic factor?

✍ Scribed by Jon Arne Søreide; Oscar A. Lea; Stener Kvinnsland


Publisher
Springer US
Year
1987
Tongue
English
Weight
566 KB
Volume
9
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


HDLG5/KIAA0583, encoding a MAGUK-family
✍ Sami Purmonen; Tytti M. Ahola; Pasi Pennanen; Nickolai Aksenov; Ya-Hua Zhuang; P 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 212 KB

## Abstract The steroid hormone progesterone is known to have profound effects on growth and differentiation of normal and malignant breast epithelial cells. The biologic actions of progesterone are exerted through the nuclear progesterone receptor‐mediated control of target gene transcription. We

Liver fatty acid-binding protein is a ne
✍ Yamazaki, Toshiyuki; Kanda, Tatsuo; Sakai, Yasuo; Hatakeyama, Katsuyoshi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 2 views

Background and Objectives: Liver fatty acid-binding protein (L-FABP) is reported as a biological marker for enterocytic differentiation. We evaluated the prognostic value of L-FABP expression for patients undergoing hepatic resection of colorectal cancer metastases. Methods: The study group comprise

Is nuclear expression of Y box-binding p
✍ Toshiharu Kamura; Hideaki Yahata; Satoshi Amada; Shinji Ogawa; Takanori Sonoda; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 2 views

## BACKGROUND. Nuclear expression of Y box-binding protein (YB-1), a member of the DNA binding protein family, has been reported to be much more highly concentrated in cisplatin-resistant cell lines than in their parental counterparts, suggesting an ability to limit cisplatin sensitivity. Moreover,

Estrogen receptors (ER) in human breast
✍ Marianne Gotteland; Evelyne May; Françoise May-Levin; Geneviève Contesso; Jean-C 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 843 KB

Background. The response to endocrine therapy is not entirely predictable from the estrogen receptor (ER) and progesterone receptor (PgR) status of primary breast tumors. The authors previously proposed a new prognostic factor, ER.R, which was based on both ER protein and mRNA levels. A previous ana